Te Ahumairangi Investment Management Ltd
Position in JNJ — Johnson & Johnson
CIK 1832237
WELLINGTON, Q2
Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,894,403
-$383,313 QoQ
Shares Held
31,084
-8.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.27%
of 13F equity value
Holder Rank
#1,251
of 4,664 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Te Ahumairangi Investment Management Ltd holds $45,755,777 across 8 Drug Manufacturers - General names. JNJ ranks #1 (17.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
31,084 | $7,894,403 | |
| 2 | AZN |
Astrazeneca PLC
|
34,479 | $6,537,907 | |
| 3 | MRK |
Merck & Co., Inc.
|
50,511 | $6,490,663 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
48,936 | $6,182,574 | |
| 5 | PFE |
Pfizer Inc
|
237,946 | $5,729,739 | |
| 6 | ABBV |
AbbVie Inc.
|
21,083 | $5,305,326 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
79,705 | $4,592,602 | |
| 8 | LLY |
ELI LILLY & Co
|
2,520 | $3,022,563 |
All Filings in JNJ
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,894,403 | 31,084 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $8,277,716 | 33,864 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,434,040 | 40,754 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $9,325,698 | 50,295 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $8,376,046 | 54,835 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $7,661,642 | 46,199 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,385,020 | 51,065 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $8,226,975 | 50,765 | Shares | Sole | 2024-11-21 | |
| 2024-06-30 | $6,741,630 | 46,125 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,301,259 | 46,155 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $7,027,437 | 44,835 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $7,764,137 | 49,850 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $9,563,745 | 57,780 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,731,400 | 49,880 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $8,110,708 | 45,914 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $7,799,459 | 47,744 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,182,145 | 46,094 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $10,427,149 | 58,834 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $10,477,011 | 61,244 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $9,648,656 | 59,744 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $9,595,116 | 58,244 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $9,572,401 | 58,244 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $8,505,444 | 54,044 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $5,693,766 | 38,244 | Shares | Sole | 2020-11-17 | |
| No filing history on record for this holder in this stock. | ||||||